Core Insights - CooperCompanies reported a fiscal first quarter revenue of $964.7 million, representing a 4% year-over-year increase [4] - The company achieved a GAAP diluted earnings per share (EPS) of $0.52, up from $0.41 in the previous year [39] - Non-GAAP diluted EPS increased to $0.92, compared to $0.85 in the same quarter last year [39] Financial Performance - CooperVision (CVI) revenue was $646.1 million, up 4% year-over-year, with organic growth of 6% [4][41] - CooperSurgical (CSI) revenue reached $318.6 million, a 3% increase from the previous year, with organic growth of 2% [10][41] - Gross margin improved to 68%, up from 67% in the prior year, driven by efficiency gains [4] Geographic Revenue Breakdown - Revenue from the Americas was $270.9 million, reflecting a 7% increase year-over-year [3] - EMEA revenue was $246.5 million, up 3% year-over-year [3] - Asia Pacific revenue decreased by 2% to $128.7 million [3] Guidance and Future Outlook - The company raised its fiscal year 2025 total revenue guidance to between $4,080 million and $4,158 million, with organic growth projected at 6% to 8% [11] - Non-GAAP diluted EPS guidance for fiscal 2025 is set between $3.94 and $4.02, an increase from previous guidance [11] Cash Flow and Expenses - Cash provided by operations was $190.6 million, leading to a free cash flow of $101.2 million after capital expenditures of $89.4 million [4] - Interest expense decreased to $26.0 million from $29.9 million in the previous year due to lower interest rates [4]

Core Viewpoint - The Cooper Companies, Inc. is set to release its first-quarter fiscal 2025 results on March 6, with expectations of revenue growth and earnings improvement compared to the previous year [1][2]. Group 1: Financial Performance Expectations - The Zacks Consensus Estimate for revenues is $982 million, reflecting a 5.4% increase from the same quarter last year [2]. - The consensus estimate for earnings is 92 cents per share, indicating an 8.2% improvement from the prior-year period [2]. - The company has consistently beaten earnings estimates in the last four quarters, with an average surprise of 4.87% [1]. Group 2: Segment Performance - Cooper Companies operates under two main segments: CooperVision (CVI) and CooperSurgical (CSI), both of which have shown strength in recent quarters [3]. - The CVI segment is expected to grow organically by 6.5-8.5% for the full year, with a projected 7.1% organic growth for the first quarter [5]. - The myopia management business, particularly MiSight, is forecasted to grow approximately 40% for fiscal 2025, supported by expansion in key markets [6]. - The CSI segment's fertility business posted 15% growth in the last reported quarter, driven by strong demand and technological advancements [7]. Group 3: Challenges and Opportunities - Supply constraints for MyDay lenses may have impacted first-quarter performance, but new manufacturing lines are expected to improve availability [4][5]. - PARAGARD, a non-hormonal IUD, faced a 10% decline in the fourth quarter due to increased competition, and sales are anticipated to remain under pressure in the upcoming quarter [9]. - The gross margin improved to 66.9% in the fourth quarter, and is expected to expand further in the soon-to-be-reported quarter due to higher production levels and cost control initiatives [10][11]. Group 4: Operational Insights - Operating income grew 16.2% in the fourth quarter and is anticipated to gain 10-12% in fiscal 2025, indicating a stable trajectory [11]. - Foreign exchange is expected to impact revenues by 1.5% and EPS by 4% in the upcoming quarter [11].

Core Viewpoint - Wall Street analysts expect The Cooper Companies (COO) to report quarterly earnings of $0.92 per share, reflecting an 8.2% year-over-year increase, with revenues projected at $982.21 million, a 5.4% increase compared to the previous year [1]. Earnings Projections - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating a collective reassessment by covering analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts predict 'Revenue by Category- CVI' at $657.69 million, indicating a year-over-year change of +5.8% [5]. - 'Revenue by Category- CSI' is expected to reach $327.66 million, reflecting a +5.7% change from the prior-year quarter [5]. - 'Revenue by Category- CSI- Office and surgical' is forecasted at $198.79 million, showing a +4% change from the previous year [5]. - 'Revenue by Category- CSI- Fertility' is projected to be $129.66 million, suggesting a +9% year-over-year change [6]. - 'Revenue by Geography- Americas' is likely to reach $267.61 million, indicating a +5.9% change [6]. - 'Revenue by Geography- Asia Pacific' is expected at $138.64 million, reflecting a +6.1% change [6]. - The consensus estimate for 'Revenue by Geography- EMEA' stands at $255.57 million, indicating a +7.3% change from the prior-year quarter [7]. Stock Performance - Over the past month, The Cooper Companies shares have recorded a return of -6.4%, compared to the Zacks S&P 500 composite's -1.3% change, suggesting that COO may perform in line with the overall market in the upcoming period [8].

Group 1: Company Overview - BTQ Technologies Corp. is a global quantum technology company focused on securing mission-critical networks [1][7] - The company specializes in post-quantum cryptography and quantum-proof security solutions to protect critical digital assets from emerging quantum threats [3][4] Group 2: Event Participation - BTQ Technologies is sponsoring the Quantum Australia Conference Brisbane 2025, which will take place from March 25 to 27 at the Brisbane Convention and Exhibition Centre [1] - The conference aims to position Australia as a global leader in quantum innovation and will feature discussions on the cybersecurity challenges posed by quantum computing [2][5] Group 3: Key Themes and Discussions - The panel discussion titled "Securing Our Assets in a Quantum Era" will address the urgent need for quantum-resistant security measures [1][5] - Insights into BTQ's pioneering approach to quantum security will be shared, focusing on real-world applications of post-quantum cryptographic solutions [4][5] Group 4: Industry Context - The Quantum Australia Conference is recognized as Australia's premier quantum industry event, bringing together researchers, business leaders, and policymakers [2] - The event emphasizes the importance of collaboration among industry leaders to develop quantum-secure systems [5]

Group 1 - CooperCompanies will report its first quarter 2025 financial results on March 6, 2025, at 4:15 PM ET [1] - A conference call to discuss the results and corporate developments will follow at 5:00 PM ET [1] - The company operates two business units: CooperVision, focused on contact lenses, and CooperSurgical, dedicated to fertility and women's healthcare [2] Group 2 - CooperCompanies is headquartered in San Ramon, CA, and has a workforce of over 16,000 [2] - The company sells products in over 130 countries and positively impacts over fifty million lives each year [2] - For more information, the company’s website is www.coopercos.com [2]

A Delaware judge has sanctioned Sheryl Sandberg, Meta’s former COO and board member, for allegedly deleting emails related to the Cambridge Analytica privacy scandal.The decision arises from a case Meta shareholders brought against Sandberg and another former Meta board member, Jeff Zients, late last year. The plaintiffs alleged that Sandberg and Zients used personal email accounts to communicate about issues relating to a 2018 shareholder lawsuit that accused Facebook leaders of violating the law — and the ...

The Cooper Companies, Inc. (COO) is well-poised for growth on the back of strong prospects in its CooperVision (CVI) and CooperSurgical (CSI) business segments. Acquisitions boost the company’s portfolio and buoy optimism. However, unfavorable currency movements and rising costs continue to hurt revenues and margins, respectively.Shares of this Zacks Rank #3 (Hold) company have risen 7.4% in the past six months compared with the industry's 4.9% growth. The S&P 500 Index has gained 5.3% in the said time fram ...

SAN RAMON, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, today announced it will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET. A live and archived webcast of this event, where applicable, will be available by accessing the CooperCompanies’ website at http://investor.coopercos.com. About CooperCompanies CooperC ...

SAN RAMON, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading medical device company, today announced it will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET. A live and archived webcast of this event, where applicable, will be available by accessing the CooperCompanies' website at http://investor.coopercos.com. About CooperCompanies CooperCo ...

PRINCETON JUNCTION, N.J., Dec. 12, 2024 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (NYSE: MG)—a leading "one source" multinational provider of integrated technology-enabled asset protection solutions, is pleased to announce the appointment of Hani Hammad as the Company’s Chief Operating Officer (COO), effective January 1, 2025. This appointment follows the recent hiring of Natalia Shuman as the Company’s President and Chief Executive Officer (CEO), to whom Mr. Hammad will report directly. In addition to his ro ...